Lianhe Chemical Technology Co., Ltd. Class A

Lianhe Chemical Technology Co., Ltd. Class A

SSZSE:002250
13.37
CNY
+0.13
(+0.98%)
12.30BMarket Cap
Oct 27Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
4.27
5
4.84
3.76
4.42
4.38
4.75
5.21
7.1
8.47
6.92
6.15
7.06
- -
Basic EPS, GAAP
0.57
0.69
0.77
0.32
0.22
0.04
0.16
0.12
0.34
0.75
-0.5
0.11
0.4
- -
Free Cash Flow per Basic Share
-0.42
-0.22
0.19
0.31
0.09
-0.16
-0.07
-0.09
-0.98
-1.18
0.02
0.71
0.78
- -
Dividend per Share
0.14
0.16
0.19
0.19
0.17
0.19
0.15
0.14
0.13
0.13
0.28
0.16
0.15
0.12
Book Value per Share
3.4
4.08
4.96
5.21
6.08
6.14
6.39
6.53
6.83
7.53
6.98
7.1
7.46
7.69
Tangible Book Value per Share
3
3.58
4.47
4.87
5.07
5.27
5.72
5.93
6.26
6.97
6.44
6.52
6.71
6.95
Basic Weighted Avg Shares
789
799
829
825
930
938
902
917
928
929
930
923
910
900
Sales/Revenue/Turnover
3,368
3,990
4,008
3,099
4,107
4,114
4,284
4,782
6,587
7,865
6,442
5,677
6,430
- -
Operating Margin (%)
16.72
17.54
18.69
9.82
7.51
6.99
13.81
12.84
9.69
10.72
1.05
8.07
9.17
- -
Depreciation Expense
149
183
252
317
373
411
446
480
571
594
775
771
880
- -
Net Income, GAAP
450
551
638
264
205
38
144
110
315
697
-465
103
362
- -
Effective Tax Rate (%)
14.03
14.88
12.43
13.24
18.7
48.84
36.84
36.19
22.52
22.05
- -
37.22
10.93
- -
Profit Margin (%)
13.35
13.81
15.92
8.51
4.98
0.91
3.37
2.3
4.79
8.86
-7.22
1.82
5.63
- -
Working Capital
548
435
927
1,176
1,947
793
1,354
869
126
763
1,499
1,182
1,043
1,540
LT Debt
623
624
625
627
1,560
8
215
664
694
1,550
2,821
2,276
1,442
1,618
Total Equity
2,706
3,371
4,182
4,394
5,660
5,720
5,971
6,068
6,329
7,218
6,758
6,876
7,133
7,368
Return on Invested Capital (%)
13.5
13.97
13.2
4.17
3.61
0.93
2.83
1.84
4.23
5.18
- -
1.51
4.27
- -
Return on Capital (%)
13.78
14.01
13.44
5.84
4.17
0.94
1.88
1.78
4.37
7.45
- -
1.18
3.83
- -
Return on Common Equity (%)
18.78
18.33
17.08
6.22
4.1
0.66
2.49
1.84
5.12
10.52
-6.95
1.6
5.49
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,562
1,894
1,783
LT Borrowings
1,429
1,446
1,606
LT Finance Leases
14
13
12
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
900
900
900
Market Capitalization
12,040
14,902
12,301

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
5,783
6,141
6,652
Cash, Cash Equivalents & STI
666
594
1,262
Accounts Receivable, Net
1,657
2,248
2,127
Inventories
2,756
2,504
2,588
Total Current Liabilities
4,741
4,945
5,112
Payables & Accruals
- -
- -
- -
ST Debt
1,562
1,894
1,783
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.84%
3.49%
3.73%
Free Cash Flow
346.19%
754.02%
8.37%
Net Income, GAAP
36.74%
53.92%
250.93%
Sales/Revenue/Turnover
6.62%
8.09%
13.27%
Total Cash Common Dividend
4.13%
11.87%
-9.29%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,466
1,512
1,381
1,318
5,677
2025
1,510
1,640
- -
1,712
6,430
2026
1,963
2,032
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.01
0.02
0.08
0.11
2025
0.05
0.19
- -
0.05
0.4
2026
0.11
0.3
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.03
0.05
0.05
0.16
2025
0.04
0.03
- -
0.03
0.15
2026
0.03
0.07
- -
- -
- -

Company Description

CEO
Ping Wang
Full Time Employees
5,936
Sector
Process industries
Industry
Chemicals: specialty
Address
8 Yongjiao Road Taizhou ZH China 318020
IPO Date
Jun 20, 2008
Business
Lianhe Chemical Technology Co., Ltd. Lianhe Chemical Technology Co., Ltd. (002250.SZ) is a China-based company principally engaged in the research, development, production, and sale of chemical products, with core operations spanning plant protection, pharmaceuticals, functional chemicals, and engineering technology services. The company offers crop protection products including herbicides, insecticides, fungicides, and plant growth regulators; pharmaceutical intermediates and active pharmaceutical ingredients; performance and functional chemicals such as fine chemicals, plastic additives, and specialty intermediates like dichlorobenzonitriles and chlorobenzonitriles; as well as custom manufacturing services, process engineering, and equipment for the pharmaceutical, agrochemical, and industrial sectors. Founded in 1985 and headquartered in Taizhou, Zhejiang Province, China, it primarily serves domestic markets with expanding international presence in Europe and Asia, employing over 5,000 staff and operating production facilities including recent expansions in Malaysia and the UK. In recent developments, the company announced plans in November 2024 to invest up to USD200 million via its Singapore unit in a three-phase manufacturing facility in Johor, Malaysia, for pesticide and pharmaceutical intermediates, new energy chemicals, enhancing global competitiveness through lower costs and tax incentives; completed the acquisition of Fine Industries Limited, including subsidiaries Fine Organics Ltd. and Fine Environmental Services in the UK, to support European expansion in crop protection and performance chemicals; and executed a share repurchase program closing in March 2025, acquiring 1.26% of its shares for CNY 80 million to optimize capital structure.